Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
9.40
+0.67 (7.67%)
Nov 21, 2024, 1:49 PM EST - Market open
Phathom Pharmaceuticals Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$22.50
Upside
+139.36%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +176.60% | Sep 13, 2024 |
Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +176.60% | Sep 6, 2024 |
Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +176.60% | Aug 30, 2024 |
Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +176.60% | Aug 23, 2024 |
Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +176.60% | Aug 19, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +197.87% | Aug 12, 2024 |
Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +176.60% | Aug 12, 2024 |
Goldman Sachs | Goldman Sachs | Hold Maintains $10 → $12 | Hold | Maintains | $10 → $12 | +27.66% | Aug 9, 2024 |
Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +176.60% | Jul 26, 2024 |
Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +176.60% | Jul 22, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +197.87% | Jul 19, 2024 |
Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +176.60% | Jul 19, 2024 |
Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +176.60% | Jul 12, 2024 |
Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +176.60% | Jul 8, 2024 |
Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +176.60% | Jun 28, 2024 |
Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +176.60% | Jun 21, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.